154065-33-5 Usage
Uses
Used in Organic Synthesis:
4-Bromo-2-iodophenyl trifluoromethyl ether, 4-Bromo-2-iodo-alpha,alpha,alpha-trifluoroanisole is used as a reaction intermediate for the synthesis of various organic compounds. Their unique reactivity and the presence of halogen atoms make them suitable for use in organic synthesis processes.
Used in Medicinal Chemistry:
4-Bromo-2-iodophenyl trifluoromethyl ether, 4-Bromo-2-iodo-alpha,alpha,alpha-trifluoroanisole is used as a building block in the development of new pharmaceutical compounds. Their unique structures and reactivity can contribute to the creation of novel drug candidates with potential therapeutic applications.
Used in Pharmaceutical Industry:
4-Bromo-2-iodophenyl trifluoromethyl ether, 4-Bromo-2-iodo-alpha,alpha,alpha-trifluoroanisole is used as a key component in the synthesis of pharmaceutical compounds. Their unique properties and reactivity can be leveraged to develop new drugs with improved efficacy and safety profiles.
Used in Chemical Research:
4-Bromo-2-iodophenyl trifluoromethyl ether, 4-Bromo-2-iodo-alpha,alpha,alpha-trifluoroanisole is used as a research tool in chemical studies. Their unique structures and reactivity can provide insights into the development of new chemical reactions and the understanding of reaction mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 154065-33-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,0,6 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 154065-33:
(8*1)+(7*5)+(6*4)+(5*0)+(4*6)+(3*5)+(2*3)+(1*3)=115
115 % 10 = 5
So 154065-33-5 is a valid CAS Registry Number.
154065-33-5Relevant academic research and scientific papers
Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof
-
Page/Page column 55, (2011/04/18)
The invention relates to substituted aromatic fluoroglycoside derivatives, and to the physiologically compatible salts and physiologically functional derivatives thereof. The invention also relates to methods of lowering blood sugar and the treatment of t
